TH-302, a hypoxia-activated prodrug with broad in vivo...

Cancer Chemotherapy and Pharmacology 2012 / 06 Vol. 69; Iss. 6

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules

Liu, Qian, Sun, Jessica D., Wang, Jingli, Ahluwalia, Dharmendra, Baker, Amanda F., Cranmer, Lee D., Ferraro, Damien, Wang, Yan, Duan, Jian-Xin, Ammons, W. Steve, Curd, John G., Matteucci, Mark D., Har
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Pages:
12
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-012-1852-8
Date:
June, 2012
File:
PDF, 413 KB
english, 2012
Conversion to is in progress
Conversion to is failed